Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN003735 | 68.0609 | 6.67 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 108.0897 | 2.52 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 110.0343 | 4.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 123.9885 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 148.0351 | 2.65 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 148.0353 | 8.11 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 159.0317 | 3.42 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 176.0432 | 4.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 183.0626 | 8.29 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 183.0626 | 9.12 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 198.1578 | 5.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 203.1257 | 5.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 213.168 | 3.76 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 214.1538 | 4.18 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 215.1834 | 3.5 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 220.0745 | 11.07 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 220.1067 | 5.81 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 222.0531 | 5.44 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 222.0533 | 6.29 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 224.0516 | 4.29 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 225.1699 | 3.74 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 227.1853 | 6.88 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 227.2148 | 6.62 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 227.2591 | 4.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 228.2057 | 9.01 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 229.1644 | 3.38 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 229.2379 | 4.24 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 231.1801 | 3.77 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 232.1778 | 4.54 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 233.1967 | 2.88 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 234.1581 | 5.77 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 234.1946 | 6.84 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 237.1306 | 3.01 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 241.2721 | 4.94 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 241.2726 | 5.1 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 245.1402 | 3.92 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 249.0742 | 7.25 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 253.1972 | 7.43 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 253.2002 | 7.51 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 253.2368 | 6.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 255.2149 | 4.93 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 255.2517 | 7.39 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 255.2523 | 7.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 255.2535 | 7.24 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 255.2869 | 5.06 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 256.2132 | 3.55 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 258.1425 | 6.75 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 260.1001 | 3.92 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 261.1664 | 6.73 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 261.2283 | 3.63 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 263.2564 | 9.11 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 264.2416 | 7.17 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 266.16 | 5.7 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 267.2875 | 5.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 269.3046 | 5.69 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 271.2103 | 4.4 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 272.085 | 6.75 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 273.2612 | 4.64 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 275.2431 | 3.96 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 276.1669 | 5.96 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 278.0834 | 4.24 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 280.0403 | 8.13 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 281.268 | 7.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 282.2512 | 5.53 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 283.2833 | 8.13 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 283.2848 | 7.7 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 285.2994 | 5.41 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 287.2787 | 4.5 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 289.256 | 4.27 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 289.2721 | 6.07 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 290.1826 | 5.57 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 292.1237 | 5.5 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 297.3004 | 7.63 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 299.2782 | 5.04 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 299.2792 | 4.95 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 301.2928 | 5.18 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 301.2933 | 5.19 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 301.2953 | 4.78 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 303.141 | 3.27 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 303.2734 | 4.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 305.0471 | 4.26 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 308.1022 | 5.99 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 308.1192 | 2.67 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 308.1952 | 5.78 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 309.2966 | 7.8 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 310.2832 | 6.02 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 311.3144 | 8.49 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 313.3305 | 5.95 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 315.2686 | 4.84 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 315.2742 | 4.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 315.3098 | 5.06 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 317.1601 | 3.62 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 317.2892 | 4.84 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 318.252 | 8.32 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 323.3138 | 8.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 324.1917 | 5.52 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 325.2936 | 6.59 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 325.327 | 8.91 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 327.3105 | 4.96 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 328.2359 | 7.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 329.3266 | 5.33 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 330.1972 | 3.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 330.2502 | 7.49 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 330.273 | 7.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 331.1764 | 3.94 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 331.3037 | 5.04 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 331.3042 | 5.11 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 331.3202 | 5.59 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 333.2647 | 4.67 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 334.0965 | 3.42 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 335.3127 | 7.25 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 335.3146 | 7.96 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 336.152 | 7.27 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 337.3288 | 8.69 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 338.2754 | 6.1 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 339.2517 | 2.07 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 340.0058 | 10.23 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 342.2512 | 8.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 343.3056 | 5.01 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 344.3262 | 8.43 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 345.3258 | 4.81 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 349.3137 | 7.01 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 351.31 | 6.87 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 351.3459 | 8.97 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 352.11 | 2.63 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 353.1922 | 7.65 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 353.3249 | 7.29 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 354.0578 | 8.41 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 355.3424 | 5.48 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 357.3232 | 5.28 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 357.3551 | 5.86 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 359.3369 | 5.58 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 360.3267 | 7.82 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 363.3286 | 7.36 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 363.3297 | 7.37 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 365.3615 | 9.43 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 366.1218 | 3.39 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 367.307 | 6.52 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 367.3727 | 10.3 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 368.3401 | 10.7 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 370.0885 | 9.19 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 370.237 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 370.3001 | 8.76 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 371.3343 | 5.53 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 373.3166 | 5 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 373.3528 | 5.91 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 373.3533 | 5.35 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 378.3458 | 5.53 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 380.2456 | 9.49 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 381.1942 | 7.73 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 386.1686 | 4.56 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 387.3249 | 8.34 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 390.3292 | 7.24 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 391.299 | 6.65 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 391.3603 | 7.37 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 395.2385 | 7.06 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 396.2464 | 4.84 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 398.382 | 7.25 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 400.3298 | 8.25 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 402.3428 | 7.05 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 406.2653 | 7.26 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 407.2764 | 6.65 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 407.2827 | 5.78 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 407.2985 | 7.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 407.3585 | 7.36 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 412.2417 | 4.49 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 415.3576 | 8.77 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 415.3675 | 5.78 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 416.3227 | 7.94 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 419.3933 | 9.09 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 424.2921 | 8.08 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 424.2929 | 9.31 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 425.3432 | 5.35 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 427.3611 | 6.03 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 428.2508 | 6.92 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 429.3785 | 6.02 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 430.3743 | 7.58 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 433.2448 | 5.59 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 434.3503 | 7.36 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 434.3538 | 7.44 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 437.2839 | 5.89 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 438.2302 | 5.99 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 439.2544 | 8.56 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 447.2774 | 6.77 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 453.2666 | 6.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 453.2792 | 5.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 457.3336 | 6.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 458.4034 | 8.17 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 458.4041 | 8.04 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 463.2968 | 6.06 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 465.3178 | 6.53 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 465.3994 | 7.79 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 466.3465 | 9.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 469.3489 | 8.1 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 469.3506 | 9.3 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 470.3693 | 6.2 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 473.3022 | 7.82 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 475.3453 | 5.27 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 477.2822 | 5.51 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 477.2838 | 5.42 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 477.3098 | 5.59 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 479.2959 | 5.78 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 479.2965 | 5.89 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 479.4209 | 8.17 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 481.3124 | 6.34 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 484.2768 | 6.88 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 489.2748 | 2.51 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 490.4184 | 9.03 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 491.4588 | 10.36 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 492.3361 | 9.57 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 492.3372 | 9.75 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 493.3103 | 5.23 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 493.3131 | 5.34 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 493.3478 | 7.23 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 495.3283 | 5.76 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 495.4036 | 7.42 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 499.2654 | 5.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 501.283 | 5.53 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 501.3608 | 6.49 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 501.4852 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 503.3481 | 8.98 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 507.3737 | 5.34 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 509.4743 | 10.34 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 514.3901 | 5.09 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 515.4144 | 9.55 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 515.4156 | 9.75 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 515.4182 | 10.5 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 518.3597 | 7.84 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 519.3274 | 5.55 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 519.3402 | 10.12 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 519.4881 | 11.17 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 521.341 | 5.81 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 521.3435 | 5.92 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 521.4244 | 8.43 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 523.2822 | 5.92 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 523.2824 | 6.08 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 523.3553 | 6.26 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 523.3576 | 6.38 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 524.1596 | 8.38 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 525.281 | 5.52 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 525.3043 | 6.64 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 525.4158 | 7.08 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 527.2937 | 5.59 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 527.2979 | 5.68 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 529.3104 | 5.98 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 529.3118 | 5.9 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 529.3351 | 6.9 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 530.3964 | 10.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 532.2687 | 7.06 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 533.3562 | 9.01 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 535.4783 | 10.48 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 537.4147 | 9.18 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 537.4158 | 7.68 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 537.506 | 11.16 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 539.4356 | 7.41 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 539.4361 | 7.33 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 539.5195 | 11.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 543.3291 | 5.56 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 543.4414 | 10.5 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 545.3394 | 5.68 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 545.3413 | 5.78 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 545.3552 | 8.98 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 545.3851 | 6.48 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 545.4725 | 10.76 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 546.3711 | 10.44 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 547.3495 | 3.08 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 547.3507 | 2.94 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 551.3986 | 5.36 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 551.4682 | 9.02 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 552.4138 | 6.98 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 553.1636 | 7.68 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 553.4441 | 7.75 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 559.4061 | 8.98 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 563.4237 | 10.44 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 564.3236 | 5.79 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 565.4177 | 2.74 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 565.4507 | 8.4 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 567.3292 | 5.55 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 568.3704 | 10.44 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 568.3754 | 10.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 569.261 | 5.66 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 569.3411 | 5.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 569.4461 | 7.07 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 571.3563 | 6.01 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 575.3951 | 6.08 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 575.4538 | 10.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 581.4452 | 7.66 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 582.3144 | 7.01 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 582.4934 | 10.29 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 583.4584 | 7.4 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 583.4619 | 7.32 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 586.3543 | 7.33 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 589.4112 | 6.48 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 591.3772 | 3.16 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 591.4485 | 10.44 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 595.4198 | 5.38 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 597.475 | 7.73 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 599.4584 | 6.61 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 603.4841 | 10.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 607.4597 | 7.78 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 609.4785 | 8.39 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 613.4722 | 7.05 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 619.2449 | 11.07 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 625.4722 | 7.64 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 627.4824 | 7.38 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 627.4871 | 7.28 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 629.6009 | 10.52 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 631.5042 | 10.22 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 631.5147 | 10.22 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 633.4377 | 6.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 639.4484 | 5.39 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 641.5009 | 7.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 643.4791 | 6.69 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 643.5924 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 647.615 | 10.52 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 648.4493 | 10.7 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 649.6306 | 11.53 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 651.4289 | 11.04 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 655.4012 | 10.23 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 656.425 | 7.4 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 656.5207 | 8.27 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 660.4515 | 9.85 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 667.4386 | 8.61 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 670.4921 | 8.28 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 670.598 | 10.53 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 671.5124 | 7.36 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 672.4135 | 7.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 673.4458 | 7.4 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 674.5294 | 8.27 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 677.4638 | 6.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 677.4972 | 8.92 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 681.5409 | 9.79 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 683.4771 | 5.42 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 684.5509 | 9.11 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 685.5215 | 7.69 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 688.183 | 10.59 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 689.4405 | 7.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 689.523 | 10.26 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 690.5585 | 9.03 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 691.5104 | 9.37 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 694.4002 | 6.93 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 695.6313 | 9.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 697.5263 | 8.33 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 699.5529 | 9.79 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 700.5453 | 8.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 701.4774 | 7.38 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 701.5698 | 10.09 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 702.5599 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 704.5781 | 9.49 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 705.5207 | 9.88 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 709.4845 | 10.13 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 709.5065 | 9.86 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 709.5377 | 9.92 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 709.5409 | 9.92 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 711.2205 | 10.62 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 713.2178 | 10.6 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 715.5393 | 7.35 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 715.5416 | 10.41 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 715.5484 | 10.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 716.5705 | 9.7 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 717.6215 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 718.5358 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 718.5909 | 10.13 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 719.5438 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 719.544 | 10.42 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 721.4925 | 6.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 721.4988 | 9.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 723.5134 | 10.29 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 727.5021 | 5.43 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 729.2281 | 9.25 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 729.5273 | 9.68 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 729.5585 | 7.67 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 730.5276 | 9.12 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 730.5882 | 10.31 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 731.0252 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 731.5423 | 10.05 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 733.4883 | 9.63 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 733.5519 | 11.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 735.5282 | 10.01 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 737.5055 | 9.45 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 738.4066 | 7.32 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 738.4835 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 739.511 | 1 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 739.5264 | 10.73 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 741.6083 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 743.5672 | 10.73 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 745.5494 | 7.02 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 745.5515 | 10.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 745.5517 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 745.5551 | 6.92 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 747.5117 | 9.82 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 747.5146 | 10.05 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 749.526 | 10.39 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 751.4996 | 6.09 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 753.5348 | 9.11 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 755.5671 | 9.45 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 757.5534 | 10.23 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 758.4815 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 759.5727 | 11.22 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 760.4768 | 9.11 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 761.5276 | 10.35 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 761.5315 | 10.5 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 763.5311 | 9.55 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 765.5129 | 6.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 765.5309 | 10.09 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 765.5519 | 10.33 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 765.5568 | 9.9 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 767.5393 | 9.58 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 767.5412 | 10.96 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 767.5742 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 771.5285 | 5.45 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 771.5727 | 10.69 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 771.5783 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 773.5323 | 10.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 775.2112 | 10.09 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 775.5458 | 10.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 775.5483 | 10.99 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 777.5434 | 10.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 779.4315 | 10.28 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 779.5458 | 9.45 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 781.5557 | 1 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 781.6397 | 11.4 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 782.5563 | 8.73 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 783.5715 | 10.31 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 784.4819 | 9.11 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 789.5374 | 9.87 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 789.5618 | 10.05 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 791.5431 | 10.64 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 791.5534 | 10.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 791.5647 | 10.01 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 791.5677 | 10.42 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 792.5353 | 9.13 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 793.4742 | 10.39 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 793.5635 | 9.69 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 793.5671 | 9.87 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 793.5885 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 799.5039 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 801.5221 | 9.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 802.4677 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 803.4412 | 10.03 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 803.5854 | 7.32 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 804.4869 | 9.13 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 804.5023 | 9.49 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 805.4508 | 9.89 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 805.5562 | 9.79 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 806.4867 | 9.12 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 806.5021 | 9.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 807.5696 | 10.23 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 807.5721 | 10.1 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 807.6605 | 11.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 809.5425 | 6.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 811.4954 | 10.96 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 811.6776 | 11.43 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 815.5597 | 5.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 817.583 | 10.31 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 819.5848 | 6.67 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 819.5972 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 831.4652 | 10.13 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 831.5688 | 9.87 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 833.4858 | 10.9 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 833.5889 | 10.16 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 835.5091 | 10.65 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 843.6056 | 10.27 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 847.5428 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 847.6127 | 7.3 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 849.2366 | 10.81 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 852.707 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 853.5584 | 9.1 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 853.5656 | 6.45 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 854.7182 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 857.4802 | 10.2 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 861.6088 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 863.629 | 9.44 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 877.2693 | 10.81 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 878.7282 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 879.2646 | 10.81 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 880.7392 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 881.4811 | 11.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 881.4827 | 10.02 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 887.4621 | 10.33 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 892.4528 | 9.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 892.5859 | 11.52 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 902.7168 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 904.4104 | 9.14 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 904.7437 | 10.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 905.4812 | 9.78 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 907.4731 | 10.1 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 908.7669 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 910.762 | 10.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 915.4987 | 10.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 920.6293 | 5.48 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 921.5717 | 7.6 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 923.2509 | 11.41 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 925.2478 | 11.41 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 928.7438 | 10.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 932.5685 | 9.6 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 933.6238 | 9.62 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 938.5725 | 9.62 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 949.6151 | 9.27 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 952.7867 | 10.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 953.2867 | 11.41 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 954.5771 | 9.27 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 954.7595 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 956.4915 | 10.72 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 956.7728 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 961.6577 | 9.62 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 971.4528 | 10.02 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 977.6528 | 9.27 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 978.7651 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 981.6073 | 8.4 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 996.5961 | 6.23 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1040.6239 | 6.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1128.6766 | 6.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1146.315 | 11.46 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1193.8046 | 11.42 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1209.7971 | 10.97 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1214.7441 | 10.97 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1214.7539 | 11.16 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1221.8259 | 11.42 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1225.7891 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1230.7517 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1237.8293 | 11.15 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1237.8312 | 10.97 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1253.8184 | 10.86 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1253.8195 | 10.71 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1253.821 | 10.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1253.8237 | 10.93 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1253.8251 | 10.86 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1260.7577 | 6.21 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1269.8116 | 10.22 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1269.818 | 10.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1401.622 | 3.11 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1463.0681 | 9.11 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1465.0821 | 9.47 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1507.0571 | 10.05 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1532.659 | 3.33 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 1763.7482 | 3.13 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003735 | 2129.6562 | 9.13 | Minutes | ST002285 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells |
